GUILDFORD, SURREY / ACCESS Newswire / March 21, 2025 / ANGLE plc (AIM:AGL), a world-leading liquid biopsy company, announces that, under the Remuneration Policy approved by the shareholders at the ...
ON ASTRAZENECA ASSAY DEVELOPMENT PROJECTS AND SUCCESSFUL COMPLETION OF EISAI CONTRACTDevelopment of both the prostate cancer androgen receptor assay and the multi-cancer DDR micronuclei assay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback